Codexis, Inc. (0I0X.L)

USD 5.58

(-2.26%)

Long Term Debt Summary of Codexis, Inc.

  • Codexis, Inc.'s latest annual long term debt in 2023 was 12.24 Million USD , down -68.02% from previous year.
  • Codexis, Inc.'s latest quarterly long term debt in 2024 Q2 was 28.36 Million USD , up 0.94% from previous quarter.
  • Codexis, Inc. reported annual long term debt of 38.27 Million USD in 2022, down -12.13% from previous year.
  • Codexis, Inc. reported annual long term debt of 43.56 Million USD in 2021, up 95.13% from previous year.
  • Codexis, Inc. reported quarterly long term debt of 28.1 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Codexis, Inc. reported quarterly long term debt of 28.36 Million USD for 2024 Q2, up 0.94% from previous quarter.

Annual Long Term Debt Chart of Codexis, Inc. (2023 - 2006)

Historical Annual Long Term Debt of Codexis, Inc. (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 12.24 Million USD -68.02%
2022 38.27 Million USD -12.13%
2021 43.56 Million USD 95.13%
2020 22.32 Million USD -10.53%
2019 24.95 Million USD 40803.28%
2018 61 Thousand USD -79.8%
2017 302 Thousand USD -65.88%
2016 885 Thousand USD -32.44%
2015 1.31 Million USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 2.57 Million USD -68.43%
2008 8.15 Million USD -36.79%
2007 12.9 Million USD 413.33%
2006 2.51 Million USD 0.0%

Peer Long Term Debt Comparison of Codexis, Inc.

Name Long Term Debt Long Term Debt Difference
Xeris Biopharma Holdings, Inc. 190.93 Million USD 93.588%
Arrowhead Pharmaceuticals, Inc. 104.6 Million USD 88.296%
Viridian Therapeutics, Inc. 20.2 Million USD 39.406%
Organovo Holdings, Inc. 888 Thousand USD -1278.716%